| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.734 | 8.617 | 3.918 | 5.835 | 4.994 | 372 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.923 | 8.679 | 3.918 | 5.835 | 4.994 | 372 | 38 | 0 | 0 | 0 |
| Total Expenses - EUR | 5.198 | 7.997 | 1.876 | 2.647 | 718 | 568 | 146 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -2.274 | 682 | 2.042 | 3.188 | 4.276 | -196 | -108 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -2.326 | 510 | 1.924 | 3.016 | 4.126 | -208 | -109 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Creasig Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 255 | 253 | 248 | 244 | 239 | 235 | 229 | 230 | 229 | 228 |
| Current Assets | 712 | 1.281 | 1.157 | 2.216 | 6.075 | 5.118 | 4.896 | 4.911 | 4.896 | 4.869 |
| Inventories | 395 | 0 | 0 | 0 | 609 | 597 | 584 | 586 | 584 | 581 |
| Receivables | 0 | 484 | 558 | 598 | 247 | 173 | 152 | 152 | 152 | 151 |
| Cash | 317 | 796 | 600 | 1.618 | 5.219 | 4.348 | 4.160 | 4.173 | 4.161 | 4.137 |
| Shareholders Funds | -4.021 | -3.470 | -1.487 | 1.557 | 5.652 | 5.338 | 5.110 | 5.126 | 5.110 | 5.082 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.988 | 5.003 | 2.893 | 903 | 661 | 14 | 15 | 15 | 15 | 15 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6622 - 6622" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Creasig Intermed Srl